HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Correlation between degradation and ultrastructure of peptidoglycan during autolysis of Escherichia coli.

Abstract
The kinetics of peptidoglycan degradation were examined under different conditions of autolysis of Escherichia coli. With cephaloridine- or moenomycin-induced autolysis, degradation did not exceed 25 to 35%, whereas in EDTA-induced autolysis it rapidly reached 65 to 70%. When nonautolyzing cells were fixed overnight with glutaraldehyde, followed by an osmium fixation, and thin sections were stained by the phosphotungstic acid method, a dark, 15-nm-thick layer of uniform appearance and constant width occupied the whole area between the inner and outer membranes of the envelope. The stained material was tentatively identified with peptidoglycan. Ultrastructural changes in this phosphotungstic acid-stained periplasmic space were investigated at different time intervals after induction of autolysis. In all cases, breakdown proceeded over the whole cell surface. During antibiotic-induced autolysis a progressive thinning down limited to the inner side of the layer was observed. During EDTA-induced autolysis, the rapid decrease in thickness correlated well with the important loss of material labeled with [3H]diaminopimelic acid. Considering these changes and the insufficient amounts of peptidoglycan (1.3 U/nm2) necessary to account for a regularly structured polymer occupying the whole 15-nm layer, it was speculated that peptidoglycan might be unevenly distributed throughout the periplasmic space.
AuthorsM Leduc, C Frehel, J van Heijenoort
JournalJournal of bacteriology (J Bacteriol) Vol. 161 Issue 2 Pg. 627-35 (Feb 1985) ISSN: 0021-9193 [Print] United States
PMID3918020 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Peptidoglycan
  • Phosphotungstic Acid
  • Edetic Acid
Topics
  • Anti-Bacterial Agents (pharmacology)
  • Bacteriolysis
  • Edetic Acid (pharmacology)
  • Escherichia coli (drug effects, metabolism, ultrastructure)
  • Peptidoglycan (metabolism)
  • Phosphotungstic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: